RecruitingNot ApplicableNCT05830305
MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors
Sponsor
The University of Hong Kong
Enrollment
140 participants
Start Date
Oct 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This randomized controlled trial investigates the efficacy and safety of mobile health intervention in managing hypertension after Intracerebral Hemorrhage (ICH).
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria3
- Primary ICH Diagnosis
- Age ≥ 18 years
- Discharge Modified Rankin Scale of ≤4
Exclusion Criteria10
- Expected life expectancy of \<1 year
- Patient or caregiver does not have access to WeRISE App.
- Patient or caregiver does not know how to use WeRISE App .
- Inability to perform home BP monitoring
- Inability to participate in follow-up activity
- Contraindication for intensive and rapid lowering of blood pressure (Known \>70% cerebral vascular stenosis; History of fall, dizziness or syncope due to hypotension; Any other medical condition that is deemed contraindicated for low blood pressure
- Bleeding tendency (Platelet count \< 75 x 10\^9/L; Known coagulation disorder)
- Severe renal impairment (Estimated glomerular filtration rate using CKD-EPI formula \<30 ml/min/1.73m2)
- Severe liver impairment (Child-Pugh C cirrhosis)
- Known contraindication or allergy to two or more anti-hypertensive classes
Interventions
OTHERMobile health intervention
A protocol-based intervention via phone calls, which includes anti-hypertensive drug adjustment and reinforcement of lifestyle modification, will be implemented.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05830305
Related Trials
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT0605963898 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT052937561 location
Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
NCT074614154 locations
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
NCT074820201 location